Home ›
Entities
› academia
› Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment
Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment
Research article (SKIN The Journal of Cutaneous Medicine, 2019) · cited 14× · AI/ML
Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment
Summary
Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment is a scholarly article[1].
Key Facts
Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment. Retrieved May 24, 2026, from https://4ort.xyz/entity/appropriate-use-criteria-for-the-integration-of-diagnostic-and-prognostic-gene-expression-profile-assays-into-the-manage
MLA“Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/appropriate-use-criteria-for-the-integration-of-diagnostic-and-prognostic-gene-expression-profile-assays-into-the-manage.
BibTeX@misc{4ortxyz_appropriate-use-criteria-for-the-integration-of-diagnostic-and-prognostic-gene-expression-profile-assays-into-the-manage_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment}}, year = {2026}, url = {https://4ort.xyz/entity/appropriate-use-criteria-for-the-integration-of-diagnostic-and-prognostic-gene-expression-profile-assays-into-the-manage}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment — https://4ort.xyz/entity/appropriate-use-criteria-for-the-integration-of-diagnostic-and-prognostic-gene-expression-profile-assays-into-the-manage (retrieved 2026-05-24)